Epigral Ltd

1. Approved Un-Audited (Standalone & Consolidated) Financial Results of the Company for the First Quarter ended on 30th June 2025; and took on record Limited Review Report thereon issued by M/s. S R B C & CO LLP Statutory Auditors of the Company.2. Approved the proposal of raising funds up to a sum of Rs.400 Crores by way of issuance of non-convertible debentures bonds and/or other debt securities etc. through permissible mode(s) within the borrowing limits of the Company in one or more tranches / series over a period of time and subject to such regulatory and other approvals as may be required.